Valuation: Compumedics Limited

Market Cap 45.95M 32.68M 28.46M 26.94M 24.47M 45.72M 3.13B 321M 124M 1.59B 123M 120M 5.09B P/E 2026
255x
P/E 2027 * 11x
Enterprise Value 45.95M 32.68M 28.46M 26.94M 24.47M 45.72M 3.13B 321M 124M 1.59B 123M 120M 5.09B EV / Sales 2026
0.85x
EV / Sales 2027 * 0.61x
Free-Float
36.04%
Yield 2026 *
-
Yield 2027 * 8.7%
1 day-2.13%
Current month-9.80%
1 month+2.22%
3 months-13.21%
6 months-24.59%
Current year-31.34%
1 week 0.22
Extreme 0.225
0.28
1 month 0.22
Extreme 0.225
0.28
Current year 0.22
Extreme 0.215
0.45
1 year 0.22
Extreme 0.215
0.45
3 years 0.15
Extreme 0.15
0.45
5 years 0.14
Extreme 0.135
0.45
10 years 0.14
Extreme 0.135
0.96
Manager TitleAgeSince
Chief Executive Officer 67 16/12/2010
Director of Finance/CFO 61 11/11/2009
Chief Tech/Sci/R&D Officer - -
Director TitleAgeSince
Chairman 67 16/12/2010
Director/Board Member 61 01/01/2000
Director/Board Member - 27/10/2022
Change 5-day change 1-year change 3-year change Capi.($)
-2.13%0.00%-17.86%+27.78% 33.48M
+1.53%+9.14%+39.29%+27.70% 240B
+1.99%+5.97%+10.14%-16.75% 146B
+0.33%+6.40%-11.56%+29.78% 135B
-0.82%+1.04%-55.79%-17.67% 63.64B
+0.16%0.00%-18.71%-16.71% 49.27B
-1.15%+1.71%+17.35%+20.56% 51.46B
+1.72%+9.24%+23.37%+34.88% 43.33B
+2.65%+6.99%+41.50%+55.81% 41.13B
+7.10%+21.82%+143.07%+67.76% 34.57B
Average +1.09%+5.20%+17.08%+21.31% 80.47B
Weighted average by Cap. +1.20%+6.57%+16.69%+16.74%

Financials

2026 2027 *
Net sales 60.3M 42.88M 37.35M 35.35M 32.12M 60M 4.11B 421M 163M 2.09B 161M 158M 6.68B 75.6M 53.77M 46.83M 44.32M 40.27M 75.23M 5.15B 528M 204M 2.62B 202M 197M 8.38B
Net income 2.3M 1.64M 1.42M 1.35M 1.23M 2.29M 157M 16.06M 6.21M 79.61M 6.14M 6.01M 255M 6M 4.27M 3.72M 3.52M 3.2M 5.97M 409M 41.9M 16.2M 208M 16.03M 15.67M 665M
Net Debt - -
Logo Compumedics Limited
Compumedics Limited is an Australia-based medical device company which is involved in the development, manufacture, and commercialization of diagnostics technology for sleep, brain and ultrasonic blood flow monitoring applications. Its geographic segments include the Americas, Australia and Asia Pacific, and Europe and the Middle East. It sells all of its product offerings in this region, including sleep diagnostic systems, clinical electroencephalograms (EEG systems), brain monitoring systems, ultrasonic blood-flow systems, supplies and technical service and support. It provides Sleep Diagnostics and Neurology Diagnostics Solutions. Its products include Compumedics Siesta, Compumedics Somfit, Compumedics Somte PSG and others. It provides a range of solutions for the neurology laboratory, from clinical epilepsy monitoring applications to Transcranial Doppler Sonography. Its other products include Grael 4K PSG, Falcon HST, Okti, Neuvo 64-512 Channel LTM EEG and others.
Employees
175
Date Price Change Volume
17/09/26 A$0.2300 -2.13% 2,000
16/09/26 A$0.2350 -14.55% 46,583
14/09/26 A$0.2750 +22.22% 67,296
11/09/26 A$0.2250 -2.17% 80,604
10/09/26 A$0.2300 -1.08% 90,333
Trader
-
Investor
-
Global
-
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.2300AUD
Average target price
0.6500AUD
Spread / Average Target
+182.61%

Annual profits - Rate of surprise

LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!